GlassScriptPhysician profile
Mario Maruthur
NPI 1356738199
$1,042.84
in general payments reported to CMS, 2019-2025
20 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.36 · 2020: $145 · 2022: $56.36 · 2023: $385 · 2024: $205 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $186.83 | 2019-2025 | |
| Pierre Fabre Pharmaceuticals, INC. | $125.02 | 2020 | |
| Organogenesis INC. | $107.08 | 2023-2025 | Puraply, Nushield |
| Amgen INC. | $88.44 | 2023-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $75.63 | 2022-2025 | Dupixent |
| Incyte Corporation | $74.75 | 2023-2024 | Opzelura |
| Novartis Pharmaceuticals Corporation | $70.78 | 2023-2025 | |
| Kerecis Limited | $54.88 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Mayne Pharma Commercial LLC | $33.64 | 2023 | |
| Lilly USA, LLC | $27.80 | 2019 | |
| Genzyme Corporation | $25.25 | 2025 | |
| Leo Pharma INC. | $24.94 | 2023 | Adbry |
| Janssen Biotech, INC. | $22.31 | 2025 | Tremfya |
| Dermavant Sciences, INC. | $21.15 | 2023 | Vtama |
| Sun Pharmaceutical Industries INC. | $19.83 | 2023 | Odomzo, Blu-U |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $19.45 | 2022 | |
| Biofrontera INC. | $19.01 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
| Paratek Pharmaceuticals, INC. | $16.90 | 2023 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.35 | 2024 | Arazlo, Cabtreo |
| Arcutis Biotherapeutics, INC. | $13.80 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Maruthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.